Markets:

Overview

News

Currencies

International

Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

9.170 -0.580 (-5.95%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

65 66 Next >

Stocks That Hit 52-Week Lows On Friday ↗

December 02, 2022

On Friday, 72 companies hit new 52-week lows.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

November 30, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Why Shares of Novavax Are Down Tuesday ↗

November 22, 2022

A disagreement over a contract sent the stock tumbling.

Via The Motley Fool

Could This Bullish News Make Novavax a Hot Buy? ↗

October 27, 2022

Can this turn the stock's fortunes around?

Via The Motley Fool

Stocks That Hit 52-Week Lows On Wednesday ↗

November 30, 2022

During Wednesday's session, 107 stocks hit new 52-week lows.

Via Benzinga

What's Going On With Novavax Stock? ↗

November 29, 2022

Novavax Inc (NASDAQ: NVAX) shares are trading higher Tuesday after the company announced the World Health Organization (WHO) issued an updated Emergency Use Listing for its Nuvaxovid vaccine as a...

Via Benzinga

Is Novavax Stock a Buy Now? ↗

November 26, 2022

There's probably not much good news coming for this biotech in the near future.

Via The Motley Fool

3 Potentially Explosive Stocks to Buy Before 2023 ↗

November 26, 2022

These stocks suffered in 2022. And they have reason to rebound.

Via The Motley Fool

Novavax Stock: Buy, Sell, or Hold in 2023? ↗

November 24, 2022

The shares are heading for almost a 90% loss this year.

Via The Motley Fool

How to Trade the High-Growth Biotech Sector in the Midst of a Bear Market ↗

November 23, 2022

Biotech is an exciting and emerging space that’s attracted increasing investor interest in recent years.

Via Benzinga

Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday ↗

November 23, 2022

U.S. stocks closed higher on Tuesday, with the Dow Jones gaining around 400 points. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

Novavax (NVAX) Stock Falls 10% After Ending Agreement With Gavi ↗

November 22, 2022

Yesterday, Novavax announced it has terminated a key agreement, sending shares of NVAX stock plunging in today's session.

Via InvestorPlace

Jack Ma's Ant Group Slapped With $1B Fine, Carl Icahn's Huge Short Position In GameStop, Novavax Culls COVID-19 Vaccine Alliance With GAVI: Top Stories Tuesday, Nov. 22 ↗

November 22, 2022

Reuters

Via Benzinga

Novavax Terminates Agreement With GAVI Alliance For Sale Of Its COVID-19 Vaccines ↗

November 22, 2022

Novavax Inc (NASDAQ: NVAX) delivered a written notice to Gavi, the Vaccine Alliance, terminating with immediate effect an agreement for the sale of its COVID-19 vaccine to low- and middle-income...

Via Benzinga

Nasdaq Bear Market: 3 Remarkable Growth Stocks Down Over 90% That Can Double Your Money by 2025 ↗

November 22, 2022

These beaten-down innovators have industry-changing potential.

Via The Motley Fool

What Is Going on With Novavax (NVAX) Stock Today? ↗

November 18, 2022

Novavax (NVAX) stock is on the move Friday after regulators in Canada approved the vaccine company's adult booster shot for Covid-19.

Via InvestorPlace

Canada Approves Novavax's COVID-19 Vaccine As Booster In Adults ↗

November 18, 2022

Health Canada has granted expanded approval to Novavax Inc's (NASDAQ: NVAX) Nuvaxovid (COVID-19 Vaccine as a homologous booster in adults aged 18 and older.

Via Benzinga

While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants

November 16, 2022

EQNX::TICKER_START (OTCQB:BIXT),(NASDAQ:NVAX),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:INO),(NASDAQ:BNTX) EQNX::TICKER_END

Via FinancialNewsMedia

Third COVID-19 Booster or Fifth Dose Not Required Despite Surge In Cases, Australian Health Authorities Say ↗

November 15, 2022

Australian health authorities have recommended against a fifth COVID-19 vaccine shot despite average daily cases having been 47% higher last week than the week before, said Health Minister Mark Butler...

Via Benzinga

2 Cheap Stocks to Buy Right Now ↗

November 15, 2022

Both companies performed well during the worst of the pandemic, but things have changed since then.

Via The Motley Fool

Here Are All 23 Stocks I've Bought During the 2022 Bear Market ↗

November 13, 2022

A historically bad year for Wall Street is a gift for long-term investors with cash at the ready.

Via The Motley Fool

Repeat COVID-19 Infection Increases Risk Of Acute Outcomes, Long COVID Symptoms, Study Shows ↗

November 11, 2022

Via Benzinga

Nasdaq Bear Market: 3 Phenomenal Bargains That Can Double Your Money by 2027 ↗

November 10, 2022

These amazing deals are ripe for the picking and poised to deliver triple-digit returns in five years.

Via The Motley Fool

Novavax Posts Unexpected Q3 Loss, But Revenue Surpass Expectations ↗

November 09, 2022

Novavax Inc (NASDAQ: NVAX) revised its FY22 sales forecast for the second time in three months amid waning demand for COVID-19 vaccines.

Via Benzinga

The Make-Or-Break Moment For Novavax: What To Watch In Third-Quarter Earnings ↗

November 08, 2022

Investors are looking for one key positive metric from Novavax's third-quarter earnings.

Via Investor's Business Daily

Novavax's Second Booster With Omicron Adapted COVID-19 Shot Shows Encouraging Immune Responses ↗

November 08, 2022

Via Benzinga

Preview: Novavax's Earnings ↗

November 07, 2022

Novavax (NASDAQ:NVAX) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Novavax will report...

Via Benzinga

7 Nasdaq Stocks Smart Investors Shouldn’t Touch With a 10-Foot Pole ↗

November 07, 2022

With macro forces changing the paradigm in the equities sector and the broader economy, it’s time to consider Nasdaq stocks to avoid.

Via InvestorPlace

Hurry! 7 Pitiful Nasdaq Stocks to Sell Before 2022 Ends. ↗

November 01, 2022

As the Fed continues to tighten the market, consider putting these seven on your list of overvalued Nasdaq stocks to sell before 2022 ends.

Via InvestorPlace

9 Health Care Stocks Whale Activity In Today's Session ↗

November 01, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

65 66 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Novavax, Inc. - Common Stock (NQ:NVAX)

All News about Novavax, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today